Tech Company Financing Transactions

R3 Vascular Funding Round

R3 Vascular, based in Mountain View, received $87 million from Deerfield Management Company, 415 CAPITAL and private investors.

Transaction Overview

Company Name
Announced On
5/20/2024
Transaction Type
Venture Equity
Amount
$87,000,000
Round
Series B
Investors
Proceeds Purpose
The company intends to use the funds to support the ELITE FDA IDE pivotal trial of its bioresorbable scaffold, MAGNITUDE®, for below-the-knee (BTK) PAD. The funding will also support additional research and development, global regulatory submissions, scale up of manufacturing processes and initial commercialization.

Company Information

Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
1145 Terra Bella Ave.
Mountain View, CA 94043
USA
Phone
Undisclosed
Email Address
Overview
At R3 Vascular, we strive to develop the best in class bioresorbable scaffolds that rival metal drug eluting stents. Our unique polymer and proprietary technologies are used to create scaffolds that balance strength with flexibility for treating peripheral arterial disease (PAD). At a 98-micron strut thickness across all its usable range of diameters, the MAGNITUDE BRS device is the thinnest BRS ever tested in this clinical setting.
Profile
R3 Vascular LinkedIn Company Profile
Social Media
R3 Vascular Company Twitter Account
Company News
R3 Vascular News
Facebook
R3 Vascular on Facebook
YouTube
R3 Vascular on YouTube

Management Team

Title
Name
Email & Social
Chairman
Jack Springer
  Jack Springer LinkedIn Profile  Jack Springer Twitter Account  Jack Springer News  Jack Springer on Facebook
Chief Executive Officer
Chris Owens
  Chris Owens LinkedIn Profile  Chris Owens Twitter Account  Chris Owens News  Chris Owens on Facebook
Chief Technical Officer
Kamal Ramzipoor
  Kamal Ramzipoor LinkedIn Profile  Kamal Ramzipoor Twitter Account  Kamal Ramzipoor News  Kamal Ramzipoor on Facebook
VP - Operations
Afsoon Fallahi
  Afsoon Fallahi LinkedIn Profile  Afsoon Fallahi Twitter Account  Afsoon Fallahi News  Afsoon Fallahi on Facebook
VP - R & D
Chang Lee
  Chang Lee LinkedIn Profile  Chang Lee Twitter Account  Chang Lee News  Chang Lee on Facebook
VP - Regulatory Affairs
Jane Beggs
  Jane Beggs LinkedIn Profile  Jane Beggs Twitter Account  Jane Beggs News  Jane Beggs on Facebook


 

 

Browse more venture capital transactions:

Prev: 5/20/2024: Oxford Endovascular venture capital transaction
Next: 5/20/2024: Overland AI venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on funding rounds that are announced publicly. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary